• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-04-29

  This study presents the first efficient method for synthesizing deuterium-labeled degarelix acetate, a third-generation GnRH receptor antagonist, supporting pharmacokinetic and metabolic studies in prostate cancer research. The work advances precise internal standard development for hormone therapy investigations and peptide drug monitoring.

• CHIR 99021 Trihydrochloride: Precision in Organoid Different

  2026-04-28

  Explore how CHIR 99021 trihydrochloride, a highly selective GSK-3 inhibitor, enables unprecedented control of self-renewal and differentiation in human intestinal organoids. This article delivers a uniquely practical, evidence-driven perspective for optimizing assay design and translational research.

• p-tau Ser356 and NUAK1: New Insights into Alzheimer’s Pathol

  2026-04-28

  This study demonstrates a Braak stage-dependent increase of tau phosphorylated at Ser356 (p-tau Ser356) in Alzheimer’s disease, highlighting its ubiquitous presence in neurofibrillary tangles and synapses. Using the NUAK1/2 inhibitor WZ4003, the authors show selective reduction of p-tau Ser356 in human brain slice cultures, revealing important differences between mouse and human ex vivo models with implications for tau-targeted therapeutic strategies.

• Decoding Macrophage Depletion: Translational Impact of Clodr

  2026-04-27

  This thought-leadership article provides mechanistic clarity and strategic guidance on the use of Clodronate Liposomes for in vivo macrophage depletion, with direct application to translational research challenges such as hepatic ischemia-reperfusion injury. By integrating insights from recent single-cell studies and scenario-driven best practices, we position APExBIO’s Clodronate Liposomes as a pivotal reagent for probing immune cell dynamics and informing next-generation therapeutic strategies.

• Tubastatin A: HDAC6 Inhibition Transforming Translational Mo

  2026-04-27

  This article explores how Tubastatin A, a highly selective HDAC6 inhibitor, enables precise and mechanistically informed translational research across cancer, neuroprotection, inflammation, and myocardial injury. By integrating preclinical evidence—including new porcine model data—strategic guidance, and workflow insights, we provide a roadmap for maximizing the impact of Tubastatin A in disease modeling and therapy development.

• SLC25A1 Drives Cisplatin Resistance in HNSCC via Senescence

  2026-04-26

  Li et al. establish SLC25A1 as a central mediator of cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) by promoting cellular senescence through H3K27 acetylation–driven gene activation. This mechanistic insight underscores SLC25A1 both as a predictive biomarker and a promising therapeutic target for overcoming chemoresistance.

• Lipid Peroxidation (MDA) Assay Kit: Precision in Oxidative S

  2026-04-25

  The Lipid Peroxidation (MDA) Assay Kit empowers researchers with dual-mode (colorimetric and fluorescence) malondialdehyde quantification for robust oxidative stress and ferroptosis studies. APExBIO’s validated workflow ensures high sensitivity and reproducibility across biological matrices, making it a cornerstone for translational and mechanistic research.

• MTT: Precision in Cell Viability and Metabolic Activity Assa

  2026-04-24

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) delivers reproducible insights in in vitro cell proliferation and metabolic activity measurement, setting itself apart with high purity and robust performance. Explore how APExBIO’s MTT streamlines experimental workflows, supports advanced research applications, and provides practical troubleshooting strategies for reliable, quantitative results.

• Hepatic sEH Regulates Osteoclastogenesis via Nrf2 Suppressio

  2026-04-24

  This study uncovers a novel liver-bone axis in osteoporosis, demonstrating that hepatic soluble epoxide hydrolase (sEH) drives osteoclastogenesis by suppressing the Nrf2 signaling pathway. The findings provide mechanistic insight into redox imbalance and highlight new avenues for targeted signaling pathway modulation in bone metabolism.

• p-Cresyl Sulfate: Advanced Workflows for Endothelial Dysfunc

  2026-04-23

  p-Cresyl sulfate is a pivotal tool for modeling uremic toxin-induced vascular complications, enabling precise analysis of endothelial dysfunction and aortic valve calcification in chronic kidney disease settings. This guide details optimized experimental workflows, troubleshooting advice, and translational applications, leveraging APExBIO’s high-purity offering for reproducible results.

• Bafilomycin A1: Redefining V-ATPase Inhibition in Functional

  2026-04-23

  Explore how Bafilomycin A1, a selective V-ATPase inhibitor, enables next-generation functional assays in cell biology and virology. This article delivers unmatched insight into practical assay design, cross-domain applications, and protocol precision.

• Dextromethorphan hydrobromide: Technical Guidance for Resear

  2026-04-22

  Dextromethorphan hydrobromide is an NMDA receptor antagonist designed for controlled neuroprotection and excitotoxicity inhibition studies in research environments. This compound is not intended for diagnostic or therapeutic applications. Reliable results require strict adherence to solubility, storage, and handling protocols.

• Homoharringtonine: Precision Cytotoxic Alkaloid for Next-Gen

  2026-04-22

  Explore the advanced mechanisms of Homoharringtonine, a potent cytotoxic alkaloid, and discover how its unique properties empower both leukemia research and SARS-CoV-2 antiviral studies. This in-depth article reveals novel protocol insights and practical applications for translational scientists.

• Ibotenic Acid in Precision Circuit Dissection: Next-Gen Neur

  2026-04-21

  Explore how Ibotenic acid, a potent NMDA receptor agonist, enables precise dissection of brain-to-spinal pain circuits and advances neurodegenerative disease modeling. This article uniquely bridges mechanistic insights with protocol design for translational neuroscience.

• A40926: Regulatory Engineering and Assay Precision in Glycop

  2026-04-21

  Explore how A40926, a leading dalbavancin precursor, advances antibiotic research through regulatory gene engineering and precise assay optimization. This article uniquely bridges biosynthetic innovation with actionable laboratory protocols.

452 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page